14 insiders reported 230 Form 4 transactions for Akero Therapeutics, Inc. (AKRO) over the past 18 months (most recent 2025-12-09). Recent activity: Young Jonathan (Chief Operating Officer) Sell 152,616 shares, Young Jonathan (Chief Operating Officer) Sell 20,000 shares, Xu Yuan (Director) Sell 9,398 shares, Judy Chou (Director) Sell 9,398 shares, Iwicki Mark T (Director) Sell 9,398 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-09 | Young Jonathan | Chief Operating Officer | Sell | 152,616 | $0 |
| 2025-12-09 | Young Jonathan | Chief Operating Officer | Sell | 20,000 | $0 |
| 2025-12-09 | Xu Yuan | Director | Sell | 9,398 | $0 |
| 2025-12-09 | Judy Chou | Director | Sell | 9,398 | $0 |
| 2025-12-09 | Iwicki Mark T | Director | Sell | 9,398 | $0 |
| 2025-12-09 | White William Richard | Chief Financial Officer | Sell | 10,179 | $0 |
| 2025-12-09 | White William Richard | Chief Financial Officer | Sell | 47,573 | $0 |
| 2025-12-09 | Rolph Timothy | Chief Scientific Officer | Sell | 43,810 | $0 |
| 2025-12-09 | Yale Catriona | Chief Development Officer | Sell | 47,573 | $0 |
| 2025-12-09 | Heyman Tomas J. | Director | Sell | 9,398 | $0 |
| 2025-12-09 | Harrison Seth Loring | Director | Sell | 136,301 | $0 |
| 2025-12-09 | Harrison Seth Loring | Director | Sell | 148,063 | $0 |
| 2025-12-09 | Harrison Seth Loring | Director | Sell | 9,398 | $0 |
| 2025-12-09 | Graham G. Walmsley | Director | Sell | 93,000 | $0 |
| 2025-12-09 | Graham G. Walmsley | Director | Sell | 1.2M | $0 |
| 2025-12-09 | Graham G. Walmsley | Director | Sell | 9,398 | $0 |
| 2025-12-09 | Rolph Timothy | Chief Scientific Officer | Sell | 238,339 | $0 |
| 2025-12-09 | Young Jonathan | Chief Operating Officer | Sell | 20,000 | $0 |
| 2025-12-09 | Young Jonathan | Chief Operating Officer | Sell | 20,000 | $0 |
| 2025-12-09 | Gangloff Scott A. | Chief Technology Officer | Sell | 5,088 | $0 |
| 2025-12-09 | Young Jonathan | Chief Operating Officer | Sell | 47,573 | $0 |
| 2025-12-09 | Cheng Andrew | President and CEO | Sell | 277,075 | $0 |
| 2025-12-09 | Cheng Andrew | President and CEO | Sell | 159,762 | $0 |
| 2025-12-09 | Henderson Jane | Director | Sell | 9,398 | $0 |
| 2025-12-09 | Yale Catriona | Chief Development Officer | Sell | 27,227 | $0 |
Source: SEC Form 4 filings · as of 2025-12-09
